Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ter Arkh ; 95(11): 919-923, 2023 Dec 22.
Artigo em Russo | MEDLINE | ID: mdl-38158946

RESUMO

The study evaluated the impact of HCV infection on the prognosis in patients with hematological malignancies. A total of 96 patients with anti-HCV antibodies were enrolled, with the age of 37.8 (3.0-81.0) years old, 39.6% had non-Hodgkin's lymphoma. Chronic hepatitis C (CHC) was diagnosed in 46.9% patients prior to malignancy development, in 38.5% patients simultaneously with malignancy, and in 14.6% patients during malignancy treatment. Clinical and biochemical signs of HCH were mild in most of the patients, minimal liver fibrosis (F0-1 by METAVIR system) was discovered in 47.3% patients, severe fibrosis or cirrhosis (F3-4) was diagnosed in 40% of participants. Only 20 (20.8%) of patients received antiviral therapy against HCV prior to enrollment. Regression analysis demonstrated that age >55 years old, late onset of antiviral therapy, and poor nutritional status were significant predictors of death from hematological malignancy. Survey conducted among physicians of hematological oncology hospitals in Saint-Petersburg revealed gaps in knowledge on presentation and risks of HCV infection, as well as on opportunities of modern antiviral therapy.


Assuntos
Neoplasias Hematológicas , Hepatite C Crônica , Hepatite C , Humanos , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Hepatite C Crônica/complicações , Hepatite C Crônica/diagnóstico , Hepatite C Crônica/tratamento farmacológico , Prognóstico , Cirrose Hepática/diagnóstico , Cirrose Hepática/epidemiologia , Cirrose Hepática/etiologia , Neoplasias Hematológicas/diagnóstico , Neoplasias Hematológicas/epidemiologia , Neoplasias Hematológicas/complicações , Antivirais/uso terapêutico , Hepatite C/complicações
2.
Morfologiia ; 150(4): 90-6, 2016.
Artigo em Russo | MEDLINE | ID: mdl-30137700

RESUMO

The problem of the formation of new lymphoid structures (neolymphogenesis) is quite controversial and widely discussed in the literature. Under normal conditions, lymphoid organs arise only in the process of fetal development (organogenesis), however in long-standing chronic inflammatory processes, nonhealing wounds, autoimmune diseases, oncologic pathology spontaneous formation of new lymphoid structures was noted. The structures of the peripheral lymphoid formations include the lymphocytes arranged singly and in clusters (infiltration), lymphoid nodules and lymph nodes. The morphogenesis of the components of lymphoid tissue and the possibility of creating artificial lymphoid structures, reproducing the function of the natural ones, is demonstrated. Important role in the development of lymphoid structures is played by mediators of inflammation, cytokines of the family of lymphotoxins, tumor necrosis factor. The possibilities of prosthetic substitution of the functions of the lymphoid structures are described for the activation of protective processes in the body.


Assuntos
Desenvolvimento Fetal/imunologia , Linfonodos , Linfócitos/imunologia , Linfotoxina-alfa/imunologia , Organogênese/imunologia , Fator de Necrose Tumoral alfa/imunologia , Animais , Humanos , Linfonodos/embriologia , Linfonodos/imunologia
3.
Adv Gerontol ; 28(3): 521-526, 2015.
Artigo em Russo | MEDLINE | ID: mdl-28509491

RESUMO

Age-related changes in mesocolic lymph node reflect the general process of ageing. In lymph node, these changes are associated with size reduction of structural and functional areas in the setting of manganese excess and iron, zinc, and selenium deficiency, which determines the reduction of lymphoid tissue functional activity in elderly and senile ages. We have realized the idea to control the lymphatic system functions using phytotherapy. Phytotherapy provides improving drainage, detoxication, and immune function of the lymph node by increasing the size of functional compartments, intensification of lymphoproliferative processes and mitigating the deficiency of the main trace elements. The identified lypmhotropic effects of phytotherapy are interconnected with endoecological well-being factor and the increase of nonspecific body resistance in late ontogenesis. This result is of practical importance for the optimization of endoecological rehabilitation.


Assuntos
Envelhecimento , Linfonodos , Vasos Linfáticos , Fitoterapia/métodos , Oligoelementos/análise , Envelhecimento/efeitos dos fármacos , Envelhecimento/imunologia , Animais , Atrofia , Biópsia/métodos , Linfonodos/efeitos dos fármacos , Linfonodos/patologia , Linfonodos/fisiopatologia , Vasos Linfáticos/efeitos dos fármacos , Vasos Linfáticos/patologia , Vasos Linfáticos/fisiopatologia , Masculino , Mesentério , Ratos , Ratos Wistar , Resultado do Tratamento
4.
Artigo em Russo | MEDLINE | ID: mdl-18038542

RESUMO

Duration of hepatitis A virus (HAV) RNA circulation in blood of patients with HA was assessed and compared with intensity of cytolytic syndrome. Detection of viral RNA was performed by RT-PCR method with specific primers to VP1/P2A region of HAV genome. 54 blood serum samples from 40 patients were prospectively studied on the presence of HAV RNA. The latterwas detected in 53.7% of serum samples. The greatest number of positive results of HAV RNA detection in blood of the patients with HA was obtained from 8th to 21st day of illness (77.4%). Prolonged viremia (42+/-9 days) was observed in more than 20% of the patients. The maximal time of HAV RNA daetection in blood serum amounted 74 days (period of follow-up). HAV RNA was present in almost all patients with AIAT activity higher than 500 U/l regardless of duration of illness.


Assuntos
Vírus da Hepatite A Humana/isolamento & purificação , Hepatite A/virologia , Alanina Transaminase/sangue , Primers do DNA , Hepatite A/sangue , Vírus da Hepatite A Humana/genética , Humanos , RNA Viral/sangue , RNA Viral/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos , Fatores de Tempo , Proteínas Estruturais Virais/genética , Viremia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA